CD16 (Russian Wikipedia)

Analysis of information sources in references of the Wikipedia article "CD16" in Russian language version.

refsWebsite

Global rank Russian rank

26nih.gov

4^th place

6^th place

14doi.org

2^nd place

3^rd place

4semanticscholar.org

11^th place

286^th place

2harvard.edu

18^th place

63^rd place

1archive.org

6^th place

9^th place

1springer.com

274^th place

350^th place

1web.archive.org

1^st place

archive.org

Aramburu J, Azzoni L, Rao A, Perussia B (September 1995). "Activation and expression of the nuclear factors of activated T cells, NFATp and NFATc, in human natural killer cells: regulation upon CD16 ligand binding". The Journal of Experimental Medicine. 182 (3): 801—10. doi:10.1084/jem.182.3.801. PMC 2192167. PMID 7650486.

doi.org

Georg, Philipp; et al. (2021). "Complement activation induces excessive T cell cytotoxicity in severe COVID-19". Cell. doi:10.1016/j.cell.2021.12.040. PMC 8712270. PMID 35032429.
Mandelboim O, Malik P, Davis DM, Jo CH, Boyson JE, Strominger JL (May 1999). "Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity". Proceedings of the National Academy of Sciences of the United States of America. 96 (10): 5640—4. Bibcode:1999PNAS...96.5640M. doi:10.1073/pnas.96.10.5640. PMC 21913. PMID 10318937.
Zhang Y, Boesen CC, Radaev S, Brooks AG, Fridman WH, Sautes-Fridman C, Sun PD (September 2000). "Crystal structure of the extracellular domain of a human FcγRIII". Immunity. 13 (3): 387—95. doi:10.1016/S1074-7613(00)00038-8. PMID 11021536.
Yeap WH, Wong KL, Shimasaki N, Teo EC, Quek JK, Yong HX, Diong CP, Bertoletti A, Linn YC, Wong SC (September 2016). "CD16 is indispensable for antibody-dependent cellular cytotoxicity by human monocytes". Scientific Reports (англ.). 6 (1): 34310. Bibcode:2016NatSR...634310Y. doi:10.1038/srep34310. PMC 5037471. PMID 27670158.
Anegón I, Cuturi MC, Trinchieri G, Perussia B (February 1988). "Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells". The Journal of Experimental Medicine. 167 (2): 452—72. doi:10.1084/jem.167.2.452. PMC 2188858. PMID 2831292.
Aramburu J, Azzoni L, Rao A, Perussia B (September 1995). "Activation and expression of the nuclear factors of activated T cells, NFATp and NFATc, in human natural killer cells: regulation upon CD16 ligand binding". The Journal of Experimental Medicine. 182 (3): 801—10. doi:10.1084/jem.182.3.801. PMC 2192167. PMID 7650486.
Garman SC, Kinet JP, Jardetzky TS (December 1998). "Crystal structure of the human high-affinity IgE receptor". Cell. 95 (7): 951—61. doi:10.1016/S0092-8674(00)81719-5. PMID 9875849. S2CID 10211658.
Goodier MR, Lusa C, Sherratt S, Rodriguez-Galan A, Behrens R, Riley EM (2016). "Sustained Immune Complex-Mediated Reduction in CD16 Expression after Vaccination Regulates NK Cell Function". Frontiers in Immunology (англ.). 7: 384. doi:10.3389/fimmu.2016.00384. PMC 5035824. PMID 27725819.
Quarona V, Zaccarello G, Chillemi A (2013). "CD38 and CD157: a long journey from activation markers to multifunctional molecules". Cytometry Part B. 84 (4): 207—217. doi:10.1002/cyto.b.21092. PMID 23576305. S2CID 205732787.
Pillay J, Tak T, Kamp VM, Koenderman L (October 2013). "Immune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: similarities and differences". Cellular and Molecular Life Sciences. 70 (20): 3813—27. doi:10.1007/s00018-013-1286-4. PMC 3781313. PMID 23423530.
Dumitru CA, Moses K, Trellakis S, Lang S, Brandau S (August 2012). "Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology". Cancer Immunology, Immunotherapy. 61 (8): 1155—67. doi:10.1007/s00262-012-1294-5. PMID 22692756. S2CID 26598520.
Elghetany MT (March 2002). "Surface antigen changes during normal neutrophilic development: a critical review". Blood Cells, Molecules & Diseases. 28 (2): 260—74. doi:10.1006/bcmd.2002.0513. PMID 12064921.
Sharma N, Vacher J, Allison JP (May 2019). "TLR1/2 ligand enhances antitumor efficacy of CTLA-4 blockade by increasing intratumoral Treg depletion". Proceedings of the National Academy of Sciences of the United States of America. 116 (21): 10453—10462. doi:10.1073/pnas.1819004116. PMC 6534983. PMID 31076558.
Schrama D, Reisfeld RA, Becker JC (February 2006). "Antibody targeted drugs as cancer therapeutics". Nature Reviews. Drug Discovery. 5 (2): 147—59. doi:10.1038/nrd1957. PMID 16424916. S2CID 15164268.

harvard.edu

ui.adsabs.harvard.edu

Mandelboim O, Malik P, Davis DM, Jo CH, Boyson JE, Strominger JL (May 1999). "Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity". Proceedings of the National Academy of Sciences of the United States of America. 96 (10): 5640—4. Bibcode:1999PNAS...96.5640M. doi:10.1073/pnas.96.10.5640. PMC 21913. PMID 10318937.
Yeap WH, Wong KL, Shimasaki N, Teo EC, Quek JK, Yong HX, Diong CP, Bertoletti A, Linn YC, Wong SC (September 2016). "CD16 is indispensable for antibody-dependent cellular cytotoxicity by human monocytes". Scientific Reports (англ.). 6 (1): 34310. Bibcode:2016NatSR...634310Y. doi:10.1038/srep34310. PMC 5037471. PMID 27670158.

nih.gov

pubmed.ncbi.nlm.nih.gov

Georg, Philipp; et al. (2021). "Complement activation induces excessive T cell cytotoxicity in severe COVID-19". Cell. doi:10.1016/j.cell.2021.12.040. PMC 8712270. PMID 35032429.
Vivier E, Morin P, O'Brien C, Druker B, Schlossman SF, Anderson P (January 1991). "Tyrosine phosphorylation of the Fc gamma RIII(CD16): zeta complex in human natural killer cells. Induction by antibody-dependent cytotoxicity but not by natural killing". Journal of Immunology. 146 (1): 206—10. PMID 1701792.
Mandelboim O, Malik P, Davis DM, Jo CH, Boyson JE, Strominger JL (May 1999). "Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity". Proceedings of the National Academy of Sciences of the United States of America. 96 (10): 5640—4. Bibcode:1999PNAS...96.5640M. doi:10.1073/pnas.96.10.5640. PMC 21913. PMID 10318937.
Zhang Y, Boesen CC, Radaev S, Brooks AG, Fridman WH, Sautes-Fridman C, Sun PD (September 2000). "Crystal structure of the extracellular domain of a human FcγRIII". Immunity. 13 (3): 387—95. doi:10.1016/S1074-7613(00)00038-8. PMID 11021536.
Yeap WH, Wong KL, Shimasaki N, Teo EC, Quek JK, Yong HX, Diong CP, Bertoletti A, Linn YC, Wong SC (September 2016). "CD16 is indispensable for antibody-dependent cellular cytotoxicity by human monocytes". Scientific Reports (англ.). 6 (1): 34310. Bibcode:2016NatSR...634310Y. doi:10.1038/srep34310. PMC 5037471. PMID 27670158.
Anegón I, Cuturi MC, Trinchieri G, Perussia B (February 1988). "Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells". The Journal of Experimental Medicine. 167 (2): 452—72. doi:10.1084/jem.167.2.452. PMC 2188858. PMID 2831292.
Aramburu J, Azzoni L, Rao A, Perussia B (September 1995). "Activation and expression of the nuclear factors of activated T cells, NFATp and NFATc, in human natural killer cells: regulation upon CD16 ligand binding". The Journal of Experimental Medicine. 182 (3): 801—10. doi:10.1084/jem.182.3.801. PMC 2192167. PMID 7650486.
Garman SC, Kinet JP, Jardetzky TS (December 1998). "Crystal structure of the human high-affinity IgE receptor". Cell. 95 (7): 951—61. doi:10.1016/S0092-8674(00)81719-5. PMID 9875849. S2CID 10211658.
Goodier MR, Lusa C, Sherratt S, Rodriguez-Galan A, Behrens R, Riley EM (2016). "Sustained Immune Complex-Mediated Reduction in CD16 Expression after Vaccination Regulates NK Cell Function". Frontiers in Immunology (англ.). 7: 384. doi:10.3389/fimmu.2016.00384. PMC 5035824. PMID 27725819.
Quarona V, Zaccarello G, Chillemi A (2013). "CD38 and CD157: a long journey from activation markers to multifunctional molecules". Cytometry Part B. 84 (4): 207—217. doi:10.1002/cyto.b.21092. PMID 23576305. S2CID 205732787.
Pillay J, Tak T, Kamp VM, Koenderman L (October 2013). "Immune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: similarities and differences". Cellular and Molecular Life Sciences. 70 (20): 3813—27. doi:10.1007/s00018-013-1286-4. PMC 3781313. PMID 23423530.
Dumitru CA, Moses K, Trellakis S, Lang S, Brandau S (August 2012). "Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology". Cancer Immunology, Immunotherapy. 61 (8): 1155—67. doi:10.1007/s00262-012-1294-5. PMID 22692756. S2CID 26598520.
Elghetany MT (March 2002). "Surface antigen changes during normal neutrophilic development: a critical review". Blood Cells, Molecules & Diseases. 28 (2): 260—74. doi:10.1006/bcmd.2002.0513. PMID 12064921.
. PMID 18768879. {{cite journal}}: |title= пропущен или пуст (справка); Cite journal требует |journal= (справка)
. PMID 21760529. {{cite journal}}: |title= пропущен или пуст (справка); Cite journal требует |journal= (справка)
. PMID 32165419. {{cite journal}}: |title= пропущен или пуст (справка); Cite journal требует |journal= (справка)
Sharma N, Vacher J, Allison JP (May 2019). "TLR1/2 ligand enhances antitumor efficacy of CTLA-4 blockade by increasing intratumoral Treg depletion". Proceedings of the National Academy of Sciences of the United States of America. 116 (21): 10453—10462. doi:10.1073/pnas.1819004116. PMC 6534983. PMID 31076558.
Schrama D, Reisfeld RA, Becker JC (February 2006). "Antibody targeted drugs as cancer therapeutics". Nature Reviews. Drug Discovery. 5 (2): 147—59. doi:10.1038/nrd1957. PMID 16424916. S2CID 15164268.

ncbi.nlm.nih.gov

Georg, Philipp; et al. (2021). "Complement activation induces excessive T cell cytotoxicity in severe COVID-19". Cell. doi:10.1016/j.cell.2021.12.040. PMC 8712270. PMID 35032429.
Mandelboim O, Malik P, Davis DM, Jo CH, Boyson JE, Strominger JL (May 1999). "Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity". Proceedings of the National Academy of Sciences of the United States of America. 96 (10): 5640—4. Bibcode:1999PNAS...96.5640M. doi:10.1073/pnas.96.10.5640. PMC 21913. PMID 10318937.
Yeap WH, Wong KL, Shimasaki N, Teo EC, Quek JK, Yong HX, Diong CP, Bertoletti A, Linn YC, Wong SC (September 2016). "CD16 is indispensable for antibody-dependent cellular cytotoxicity by human monocytes". Scientific Reports (англ.). 6 (1): 34310. Bibcode:2016NatSR...634310Y. doi:10.1038/srep34310. PMC 5037471. PMID 27670158.
Anegón I, Cuturi MC, Trinchieri G, Perussia B (February 1988). "Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells". The Journal of Experimental Medicine. 167 (2): 452—72. doi:10.1084/jem.167.2.452. PMC 2188858. PMID 2831292.
Aramburu J, Azzoni L, Rao A, Perussia B (September 1995). "Activation and expression of the nuclear factors of activated T cells, NFATp and NFATc, in human natural killer cells: regulation upon CD16 ligand binding". The Journal of Experimental Medicine. 182 (3): 801—10. doi:10.1084/jem.182.3.801. PMC 2192167. PMID 7650486.
Goodier MR, Lusa C, Sherratt S, Rodriguez-Galan A, Behrens R, Riley EM (2016). "Sustained Immune Complex-Mediated Reduction in CD16 Expression after Vaccination Regulates NK Cell Function". Frontiers in Immunology (англ.). 7: 384. doi:10.3389/fimmu.2016.00384. PMC 5035824. PMID 27725819.
Pillay J, Tak T, Kamp VM, Koenderman L (October 2013). "Immune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: similarities and differences". Cellular and Molecular Life Sciences. 70 (20): 3813—27. doi:10.1007/s00018-013-1286-4. PMC 3781313. PMID 23423530.
Sharma N, Vacher J, Allison JP (May 2019). "TLR1/2 ligand enhances antitumor efficacy of CTLA-4 blockade by increasing intratumoral Treg depletion". Proceedings of the National Academy of Sciences of the United States of America. 116 (21): 10453—10462. doi:10.1073/pnas.1819004116. PMC 6534983. PMID 31076558.

semanticscholar.org

api.semanticscholar.org

Garman SC, Kinet JP, Jardetzky TS (December 1998). "Crystal structure of the human high-affinity IgE receptor". Cell. 95 (7): 951—61. doi:10.1016/S0092-8674(00)81719-5. PMID 9875849. S2CID 10211658.
Quarona V, Zaccarello G, Chillemi A (2013). "CD38 and CD157: a long journey from activation markers to multifunctional molecules". Cytometry Part B. 84 (4): 207—217. doi:10.1002/cyto.b.21092. PMID 23576305. S2CID 205732787.
Dumitru CA, Moses K, Trellakis S, Lang S, Brandau S (August 2012). "Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology". Cancer Immunology, Immunotherapy. 61 (8): 1155—67. doi:10.1007/s00262-012-1294-5. PMID 22692756. S2CID 26598520.
Schrama D, Reisfeld RA, Becker JC (February 2006). "Antibody targeted drugs as cancer therapeutics". Nature Reviews. Drug Discovery. 5 (2): 147—59. doi:10.1038/nrd1957. PMID 16424916. S2CID 15164268.

springer.com

adisinsight.springer.com

Margetuximab (англ.). AdisInsight. Дата обращения: 1 февраля 2017. Архивировано 28 августа 2017 года.

web.archive.org

Margetuximab (англ.). AdisInsight. Дата обращения: 1 февраля 2017. Архивировано 28 августа 2017 года.